These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 7872690)

  • 1. An in vitro and in vivo study of antitumor effects of genistein on hormone refractory prostate cancer.
    Naik HR; Lehr JE; Pienta KJ
    Anticancer Res; 1994; 14(6B):2617-9. PubMed ID: 7872690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral cyclophosphamide and oral hydroxyurea in the treatment of hormone refractory prostate cancer in rats.
    Naik H; Lehr J; Akhtar A; Pienta K
    Anticancer Res; 1994; 14(6B):2681-4. PubMed ID: 7872701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system.
    Getzenberg RH; Light BW; Lapco PE; Konety BR; Nangia AK; Acierno JS; Dhir R; Shurin Z; Day RS; Trump DL; Johnson CS
    Urology; 1997 Dec; 50(6):999-1006. PubMed ID: 9426741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pentosan inhibits angiogenesis in vitro and suppresses prostate tumor growth in vivo.
    Nguyen NM; Lehr JE; Pienta KJ
    Anticancer Res; 1993; 13(6A):2143-7. PubMed ID: 7507655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genistein inhibits proliferation and in vitro invasive potential of human prostatic cancer cell lines.
    Santibáñez JF; Navarro A; Martínez J
    Anticancer Res; 1997; 17(2A):1199-204. PubMed ID: 9137471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo antitumor activity of bropirimine against PAIII and Dunning MAT-LyLu rodent prostate cancers.
    Sarosdy MF; Higdon AL; Demoor CA
    J Urol; 1996 Jun; 155(6):2085-9. PubMed ID: 8618341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of prostate cancer metastasis in vivo: a comparison of 1,23-dihydroxyvitamin D (calcitriol) and EB1089.
    Lokeshwar BL; Schwartz GG; Selzer MG; Burnstein KL; Zhuang SH; Block NL; Binderup L
    Cancer Epidemiol Biomarkers Prev; 1999 Mar; 8(3):241-8. PubMed ID: 10090302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An orally active Amazonian plant extract (BIRM) inhibits prostate cancer growth and metastasis.
    Dandekar DS; Lokeshwar VB; Cevallos-Arellano E; Soloway MS; Lokeshwar BL
    Cancer Chemother Pharmacol; 2003 Jul; 52(1):59-66. PubMed ID: 12734674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of castanospermine on the metastatic properties of prostate cancer cells.
    Yee CS; Schwab ED; Lehr JE; Quigley M; Pienta KJ
    Anticancer Res; 1997; 17(5A):3659-63. PubMed ID: 9413219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antisense TRPM-2 oligodeoxynucleotides chemosensitize human androgen-independent PC-3 prostate cancer cells both in vitro and in vivo.
    Miyake H; Chi KN; Gleave ME
    Clin Cancer Res; 2000 May; 6(5):1655-63. PubMed ID: 10815883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate cancer treatment is enhanced by genistein in vitro and in vivo in a syngeneic orthotopic tumor model.
    Wang Y; Raffoul JJ; Che M; Doerge DR; Joiner MC; Kucuk O; Sarkar FH; Hillman GG
    Radiat Res; 2006 Jul; 166(1 Pt 1):73-80. PubMed ID: 16808622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antitumor effects of the quinoline-3-carboxamide linomide on Dunning R-3327 rat prostatic cancers.
    Ichikawa T; Lamb JC; Christensson PI; Hartley-Asp B; Isaacs JT
    Cancer Res; 1992 Jun; 52(11):3022-8. PubMed ID: 1591718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical studies of gossypol in prostate carcinoma.
    Naik H; Petrylak D; Yagoda A; Lehr J; Akhtar A; Pienta K
    Int J Oncol; 1995 Jan; 6(1):209-13. PubMed ID: 21556526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Taxol synergizes with antioxidants in inhibiting hormal refractory prostate cancer cell growth.
    Ping SY; Hour TC; Lin SR; Yu DS
    Urol Oncol; 2010; 28(2):170-9. PubMed ID: 18818108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of VEGF-mediated autocrine and paracrine interactions between prostate cancer cells and vascular endothelial cells by soy isoflavones.
    Guo Y; Wang S; Hoot DR; Clinton SK
    J Nutr Biochem; 2007 Jun; 18(6):408-17. PubMed ID: 17142033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of prostate cancer in the rat with the synthetic retinoid fenretinide.
    Pienta KJ; Nguyen NM; Lehr JE
    Cancer Res; 1993 Jan; 53(2):224-6. PubMed ID: 7678070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of prostate cancer growth by 9-aminocamptothecin and estramustine.
    Naik H; Lehr JE; Pienta KJ
    Urology; 1996 Sep; 48(3):508-11. PubMed ID: 8804514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tranilast inhibits hormone refractory prostate cancer cell proliferation and suppresses transforming growth factor beta1-associated osteoblastic changes.
    Izumi K; Mizokami A; Li YQ; Narimoto K; Sugimoto K; Kadono Y; Kitagawa Y; Konaka H; Koh E; Keller ET; Namiki M
    Prostate; 2009 Aug; 69(11):1222-34. PubMed ID: 19434660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pan-trk inhibition decreases metastasis and enhances host survival in experimental models as a result of its selective induction of apoptosis of prostate cancer cells.
    Weeraratna AT; Dalrymple SL; Lamb JC; Denmeade SR; Miknyoczki S; Dionne CA; Isaacs JT
    Clin Cancer Res; 2001 Aug; 7(8):2237-45. PubMed ID: 11489797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential of soybean foods as a chemoprevention approach for human urinary tract cancer.
    Su SJ; Yeh TM; Lei HY; Chow NH
    Clin Cancer Res; 2000 Jan; 6(1):230-6. PubMed ID: 10656454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.